Results 11 to 20 of about 213,637 (257)

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer

open access: yesInternational Journal of Nanomedicine, 2015
Liang Huang,1,2 Sheng Chen,1,2 Ling Yao,1,2 Guangyu Liu,1,2 Jiong Wu,1,2 Zhiming Shao1–3 1Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, 2Department of Oncology, Shanghai Medical College, 3Institutes of ...
Huang L   +5 more
doaj   +1 more source

Differential expression of mTOR signalling components in drug resistance in ovarian cancer [PDF]

open access: yes, 2010
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright @ 2010 The International Institute of Anticancer Research.Background/Aim: A limitation to successful cancer ...
Karteris, E   +5 more
core   +5 more sources

MDA-MB-231-MATRIGEL-PACLITAXEL

open access: yes, 2023
TNBC cells of the MDA-MB-231 cell line (transfected with  GFP) were cultured in Matrigel scaffold for 15 days.  Paclitaxel was administered on day 5.
Nikolaos Dimitriou (10179131)
core   +1 more source

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]

open access: yes, 2007
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J   +14 more
core   +1 more source

Confocal Raman data analysis enables identifying apoptosis of MCF-7 cells caused by anticancer drug paclitaxel [PDF]

open access: yes, 2013
Confocal Raman microscopy is a noninvasive, label-free imaging technique used to study apoptosis of live MCF-7 cells. The images are based on Raman spectra of cells components, and their apoptosis is monitored through diffusion of cytochrome c in ...
Salehi, Hamideh   +8 more
core   +1 more source

Paclitaxel and cancer treatment: Non-mitotic mechanisms of paclitaxel action in cancer therapy

open access: yes, 2022
Paclitaxel (trade name Taxol) is a key drug used in chemotherapy for many solid tumors including ovarian, breast, lung, and prostate cancer. In the current treatment of ovarian cancer, paclitaxel is used as a frontline agent in combination with cisplatin
Xu, Xiang-Xi   +5 more
core   +1 more source

Supplementary Material for: Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel

open access: yes, 2023
We present a rare phenomenon of a soft tumor hanging on the woman’s left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer.
Yongshun Huang (746405)   +3 more
core   +1 more source

Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel [PDF]

open access: yes, 2013
Introduction: Sorafenib, a multitarget kinase inhibitor, targets members of the mitogen-activated protein kinase (MAPK) pathway and VEGFR kinases.
John M Kirkwood   +55 more
core   +2 more sources

Paclitaxel-treated siSBF2 cells reveal candidate genes exclusive to this group.

open access: yes, 2022
A) Volcano plot of the comparison between vehicle-treated NTC and siSBF2 cells. 15,271 differentially expressed genes were detected in the analysis, with SBF2 being the only gene that reached statistical significance (FDR = 0.002, logFC = -1.60.) B ...
Jill C. Fehrenbacher (11909909)   +12 more
core   +1 more source

Paclitaxel Induces Acute Pain via Directly Activating Toll like Receptor 4

open access: yesMolecular Pain, 2015
Paclitaxel, a powerful anti-neoplastic drug, often causes pathological pain, which significantly reduces the quality of life in patients. Paclitaxel-induced pain includes pain that occurs immediately after paclitaxel treatment (paclitaxel-associated ...
Xisheng Yan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy